Related Experiment Video
Updated: Aug 8, 2026

06:42
Murine Skin Transplantation
Published on: January 16, 2008
24.1K
Abdominal Wall Transplantation: Skin as a Sentinel Marker for Rejection
U A Gerlach1,2, G Vrakas1, B Sawitzki3
1Department of Transplant Surgery, Oxford University Hospitals and University of Oxford, Oxford, UK.
Summary
Abdominal wall transplantation (AWTX) improves outcomes after intestinal transplantation (ITX). The transplanted abdominal wall skin acts as a sentinel marker, aiding in diagnosing bowel dysfunction and preventing unnecessary immunosuppression.
Area of Science:
- Transplantation immunology
- Gastroenterology
- Surgical innovation
Background:
- Abdominal wall transplantation (AWTX) is a key technique for complex abdominal closure post-intestinal transplantation (ITX).
- The immunological role of the transplanted abdominal wall (AW) in diagnosing post-transplant bowel dysfunction requires further investigation.
Purpose of the Study:
- To evaluate the impact of AWTX on patient and graft survival after ITX.
- To determine if the AW skin serves as a sentinel marker for immunological activity and aids in differential diagnosis of bowel dysfunction.
Main Methods:
- Retrospective analysis of 29 intestinal transplantations in 28 patients (2008-2014).
- Comparison between a solid organ transplant (SOT) group and a SOT-AWTX group.
- Standardized induction (alemtuzumab) and maintenance (tacrolimus) immunosuppression protocols were used.
Main Results:
- Patient survival was similar (67% vs. 61%) between groups.
- The SOT-AWTX group demonstrated faster recovery, superior graft survival (79% vs. 60%), and lower rejection rates (7% vs. 27%).
- The SOT-AWTX group had fewer misdiagnoses of viral infection as rejection (14% vs. 33%).
Conclusions:
- AWTX is associated with improved intestinal graft survival and reduced rejection rates.
- The AW skin functions as an immune modulator and sentinel marker, crucial for accurate diagnosis and optimizing immunosuppression.
- This approach aids in preventing graft rejection and avoiding over-immunosuppression for non-graft-related bowel dysfunction.

